Q1 2025 13F Holders as of 3/31/2025
-
Type / Class
-
Equity / Common
-
Shares outstanding
-
22.2M
-
Number of holders
-
426
-
Total 13F shares, excl. options
-
19.2M
-
Shares change
-
+425K
-
Total reported value, excl. options
-
$4.67B
-
Value change
-
+$52.9M
-
Put/Call ratio
-
1.13
-
Number of buys
-
190
-
Number of sells
-
-246
-
Price
-
$243.56
Significant Holders of BIO-RAD LABORATORIES, INC. - Common (BIO) as of Q1 2025
517 filings reported holding BIO - BIO-RAD LABORATORIES, INC. - Common as of Q1 2025.
BIO-RAD LABORATORIES, INC. - Common (BIO) has 426 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 19.2M shares
of 22.2M outstanding shares and own 86.49% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (2.02M shares), VANGUARD GROUP INC (1.91M shares), First Eagle Investment Management, LLC (1.57M shares), Veritas Asset Management LLP (913K shares), DIMENSIONAL FUND ADVISORS LP (877K shares), ARIEL INVESTMENTS, LLC (725K shares), STATE STREET CORP (695K shares), EARNEST PARTNERS LLC (600K shares), VAN ECK ASSOCIATES CORP (597K shares), and BANK OF AMERICA CORP /DE/ (431K shares).
This table shows the top 426 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.